Hialeah, FLNCT07493304Now EnrollingIRB Ready

Venous Thromboembolism (VTE) Clinical Trial in Hialeah, FL

Access cutting-edge venous thromboembolism (vte) treatment through this phase 3 clinical trial at a research site in Hialeah. Study-provided care at no cost to qualified participants.

Sponsored by Regeneron Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Hialeah location

Preparing your pre-screening questions…

Expert Care in Hialeah

Access venous thromboembolism (vte) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related venous thromboembolism (vte) treatment provided free

Apply for This Hialeah Location

Check if you qualify for this venous thromboembolism (vte) clinical trial in Hialeah, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Hialeah

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Hialeah site if eligible
  4. 4Begin participation

About This Venous Thromboembolism (VTE) Study in Hialeah

This study is researching an experimental drug called REGN7508 (called "study drug") and will consist of 2 parts: Part 1 and Part 2. The study is focused on participants with or without cancer who develop blood clots in certain veins (called Deep Vein Thrombosis \[DVT\]) that block blood flow (Part 1) or focused on participants with cancer who develop blood clots in certain veins (DVT) or the lungs (also called Pulmonary Embolism \[PE\]) (Part 2). The aim of the study is to see how safe and effective the study drug is at treating and preventing further blood clots in participants with or without cancer (Part 1) or in participants with cancer (Part 2) compared with another treatment (apixaban). The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)

Sponsor: Regeneron Pharmaceuticals

Who Can Participate

Inclusion Criteria

Has an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2 at the time of screening and day 1 prior to first dose of study intervention
In Part 1 participants with cancer and Part 2 participants: Histologically confirmed diagnosis of malignant solid or select hematologic tumor (other than basal-cell or squamous-cell carcinoma of the skin alone) as described in the protocol
Part 1 additional criteria:
Has newly diagnosed symptomatic lower extremity DVT or incidentally-detected proximal lower extremity DVT (eg, popliteal or femoral) within 5 days (120 hours) of randomization (with imaging confirmation)
Anticoagulation therapy with a therapeutic dose of a Direct Oral Anticoagulant (DOAC) for at least 3 months is indicated for the newly diagnosed proximal lower extremity DVT
Part 2 additional criteria:
Newly diagnosed VTE within 5 days (120 hours) of randomization (with imaging confirmation) as described in the protocol
Anticoagulation therapy with a therapeutic dose of a DOAC for at least 6 months is indicated for newly diagnosed VTE Key

Exclusion Criteria

Is at high risk of intracranial bleeding in the opinion of the investigator
Known bleeding conditions (eg, Hemophilia A or B, von Willebrand's disease), hemorrhagic tumor sites, or other conditions with a high risk for bleeding (eg, hepatic disease associated with coagulopathy)
Contraindication to anticoagulation in the opinion of the investigator
Life expectancy of \< 6 months
Part 1 participants with cancer and Part 2 additional exclusion criteria:
Has acute leukemia or myelodysplastic syndrome
Has primary brain tumor
Has brain metastases as described in the protocol
Part 1 additional exclusion criteria:
Has a symptomatic PE
Has an asymptomatic (incidentally-diagnosed) PE in a segmental or larger pulmonary artery
Part 2 additional exclusion criteria: PE leading to hemodynamic instability as described in the protocol Note: Other Protocol Defined Inclusion/ Exclusion Criteria Apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Hialeah?

Yes, this clinical trial (NCT07493304) has an active research site in Hialeah, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Venous Thromboembolism (VTE) Treatment Options in Hialeah, FL

If you're searching for venous thromboembolism (vte) treatment options in Hialeah, FL, this clinical trial (NCT07493304) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Hialeah research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced venous thromboembolism (vte) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all venous thromboembolism (vte) clinical trials near you to find additional studies recruiting in your area.

More Deep Vein Thrombosis Trials in Hialeah, FL

See all deep vein thrombosis clinical trials recruiting in Hialeah — not just this study.

Browse Deep Vein Thrombosis Trials in Hialeah →

Ready to Join in Hialeah?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Hialeah, FL